The world could be only a few years away from a usable cancer vaccine, according to the couple who helped to create the Pfizer/BioNtech COVID-19 vaccine
The world could be only a few years away from a usable cancer vaccine, according to the couple who helped to create the Pfizer/BioNtech COVID-19 vaccine
NEW YORK CITY (dpa-AFX) - The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use or CHMP has recommended marketing authorization for a 3-microgram dose of COMIRNATY
The couple who co-founded BioNTech, the pharmaceutical company that partnered with Pfizer to create the COVID-19 vaccine, says that a cancer vaccine could be available by 2030.
Given the billions the government is spending on consumption vouchers and free airline tickets, it can pay seniors to get triple-vaccinated, which could save their lives. After doing so, it should scrap all other restrictions, thus safeguarding the economy and people’s sanity.
NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) and BioNTech SE (BNTX) Thursday announced positive early data from the Phase 2/3 study of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine booster
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for a 10-µg booster dose of their Omicron